Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
0.613
-0.028 (-4.42%)
Dec 20, 2024, 4:00 PM EST - Market closed
Lyell Immunopharma Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Lyell Immunopharma stock have an average target of 1.00, which predicts an increase of 63.21% from the current stock price of 0.61.
Analyst Consensus: Sell
* Price targets were last updated on Nov 12, 2024.
Analyst Ratings
The average analyst rating for LYEL stock from 2 stock analysts is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $1 | Hold | Reiterates | $1 | +63.21% | Nov 12, 2024 |
| B of A Securities | B of A Securities | Strong Buy → Sell Downgrades $6 → $1 | Strong Buy → Sell | Downgrades | $6 → $1 | +63.21% | Oct 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $1 | Hold | Reiterates | $1 | +63.21% | Oct 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $1 | Hold | Reiterates | $1 | +63.21% | Aug 19, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $9 → $6 | Strong Buy | Maintains | $9 → $6 | +879.27% | Jun 27, 2024 |
Financial Forecast
Revenue This Year
22.44K
from 130.00K
Decreased by -82.74%
Revenue Next Year
n/a
from 22.44K
EPS This Year
-0.80
from -0.93
EPS Next Year
-0.86
from -0.80
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 52,500 | n/a | n/a |
| Avg | 22,440 | n/a | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -59.6% | - | - |
| Avg | -82.7% | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.82 | -0.86 | -0.79 |
| Avg | -0.80 | -0.86 | -0.77 |
| Low | -0.76 | -0.84 | -0.74 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.